Literature DB >> 34215294

Expanding the neurological and behavioral phenotype of White-Sutton syndrome: a case report.

Bernadette Donnarumma1, Maria Pia Riccio2, Gaetano Terrone1,2, Melania Palma1, Pietro Strisciuglio1, Iris Scala3.   

Abstract

BACKGROUND: White-Sutton (WHSUS) is a recently recognized syndrome caused by mutations of the POGZ gene. Approximately 70 patients have been reported to date. Intellectual disability, hypotonia, behavioral abnormalities, autism, and typical facial dysmorphisms are recognized as WHSUS features; however, still few patients receive a comprehensive psychometric, behavioral and neurological examination. In this report, we describe the pediatric, dysmorphological, neurological, psychometric and behavioral phenotype in a new WHSUS patient due to a novel heterozygous POGZ mutation, highlighting the distinctive epileptic phenotype and the cognitive pattern. CASE
PRESENTATION: The patient, an 8 years-old girl, presented history of hypotonia, motor and speech delay, and distinctive facial features. The diagnosis of WHSUS followed the identification of the de novo variant p.Asp828GlyfsTer36 (c.2482dupG) in the POGZ gene. The patient showed a distinctive neurological phenotype with the occurrence of both paroxysmal not-epileptic events in the first 6 months of age and EEG abnormalities without evidence of clinical seizures after the first year of age. Psychological and behavioral testing highlighted moderate intellectual and communication deficit, mild autism spectrum and visual-motor integration deficit.
CONCLUSIONS: This is the first described case of WHSUS with a co-existence of paroxysmal not-epileptic events and abnormal EEG without seizures in the same patient. Together with the available literature data, this observation suggests that paroxysmal not-epileptic events could be more frequent than expected and that this feature belongs to the WHSUS phenotypic spectrum. Autism is a known comorbidity of WHSUS but is still poorly investigated. Specific clinical testing could help detect also mild autistic phenotypes and better define autism prevalence in POGZ-related syndrome. Special attention should be given to symptoms such as stereotypies, social withdrawal, and hyperactivity that, when present, should be considered as possible signs of autism symptoms. The dissection of the neurological and behavioral phenotype is crucial for individualized therapies tailored to patient's needs.

Entities:  

Keywords:  Autism; Case report; Cognitive profile; EEG abnormalities; Epilepsy; POGZ; POGZ mutation; Paroxysmal not-epileptic events; White-Sutton syndrome

Mesh:

Year:  2021        PMID: 34215294      PMCID: PMC8254207          DOI: 10.1186/s13052-021-01101-9

Source DB:  PubMed          Journal:  Ital J Pediatr        ISSN: 1720-8424            Impact factor:   2.638


Background

White-Sutton (WHSUS, MIM #616364) is a recently recognized syndrome caused by mutations of the POGZ (pogo transposable element-derived protein with zinc finger domain) gene, encoding for a multidomain nuclear protein that regulates chromatin remodeling, chromosome segregation and mitotic progression, making the majority of cells to prematurely exit mitosis with consequent depletion of neurogenic progenitor cells [1, 2]. WHSUS is characterized by developmental delay, intellectual disability, hypotonia, behavioral abnormalities, autism, and typical facial dysmorphisms [3]. Patients may also present short stature, microcephaly, cerebral malformations, strabismus, visual impairment, hearing loss and gastrointestinal disorders such as feeding difficulties, gastroesophageal reflux, and constipation [4]. The definition of the specific neuropsychological pattern of WHSUS is still ongoing. A recent retrospective study of 19 subjects affected by WHSUS outlined differences in intellectual efficiency, ranging from learning disability to severe intellectual deficit, and the presence of behavioral disorders including anxiety, stereotypies, social withdrawal, and hyperactivity. Language, attention, executive and social skills were mostly impaired in the cohort [5]. Researchers underline that only a minority of patients with WHSUS undergo to specific psychometric testing able to distinguish between intellectual and learning disability and that few of them perform behavioral tests [5]. Indeed, in this first neuropsychological evaluation of a WHSUS cohort, only one patient was specifically tested for autism. The epileptic phenotype in WHSUS is an additional clinical feature deserving further investigation. To the best of our knowledge, only 14 patients with WHSUS and epilepsy were reported in the literature. Medical reports plus EEG were available in 7 patients [4, 6–8]; among these, paroxysmal not-epileptic events were described in 1 subject [7] while EEG abnormalities without clinical seizures in 2 subjects [6] (Table 1). The co-existence of both paroxysmal not-epileptic events and abnormal EEG without clinical seizures in the same subject was never described so far.
Table 1

Genetic and phenotypic characterization of the present case and comparison with other WHSUS patients with paroxysmal not-epileptic events or EEG abnormalities without seizures

Present caseFerretti et al. 2019 [7]Stessman et al. 2016 [6]
Gene variant (POGZ gene: NM_015100.3)p.Asp828GlyfsTer36 (c.2482dupG)p.Leu904* (c.2711 T > G)p.Gln1283* (c.3847C > T)p.Glu1154Thrfs*4 (c.3456_3457del)
Age at onset3 months4 monthsn.r.n.r.
Age at diagnosis8 yearsn.r.n.r.n.r.
Dysmorphic featuresHigh and broad forehead; Bitemporal narrowing; Hypertelorism; Up-slanting and long palpebral fissures; Midface hypoplasia; Broad nasal bridge, anteverted nares; Protruding tongue; Macrostomy; Incisors diastasis; Clinodactyly of the fifth fingers; 4th toes brachydactyly and clinodactyly; Sandal gap.High and broad forehead; Bitemporal narrowing; Epicanthus; Broad nasal bridge; Macrostomy; Down-turned corners of the mouth; Poinetd chin; Clinodactyly.Brachycephaly; High nasal bridge, slight deviation of the nose, upturned tip of the nose; Thin upper lip.Brachycephaly; Flat midface; Hypertelorism; Epicanthic folds.
GrowthHeight 25th centile, BMI z-score 1.84n.r.Height 0.6th centile, BMI z-score 1.8Height 30th centile, BMI z-score 1.8
Microcephaly++
Motor skillsHypotonia; Motor delay; Fine motor skill deficit; Visual-motor integration deficit; Clumsiness.Hypotonia; Severe psycho-motor delay.Mild/moderate motor delayMild motor delay
LanguageSpeech delay; EcholaliaAbsent speechLanguage skills regressionSpeech delay
Intellectual disabilityIQ 60SevereSevereIQ of 55 (at 6 y)
Autism++
ADHDn.r.n.r.n.r.
SeizuresParoxysmal not-epileptic events; EEG abnormalities without epilepsy (sharp waves over the biemispheric centro-temporal areas)Paroxysmal not-epileptic events; EEG abnormalities with epilepsy (bitemporal frontal spike-and-waves abnormalities)EEG epileptic abnormalities without epilepsy (bilateral frontal abnormalities)EEG epileptic abnormalities without epilepsy
Brain imagingLateral ventricle enlargement; Fronto-temporo-parietal cortical atrophy.Cortical and subcortical cerebral atrophy associated with enlargement of the third ventricle and temporal horns of lateral ventricles; thin corpus callosumn.r.n.r.
Eye abnormalityEsotropiaHigh hypermetropia
Hearing loss+ (sensorineural)n.r.+ (conductive)
Gastrointestinal involvementPoor feeding; Gastric distension.Feeding problems
Sleep disordersn.r.+n.r.
Congenital Heart Defectn.r.n.r.n.r.
OtherDorsal HyperkyphosisVisual inattentionanxiety, self mutilationn.r.

ADHD Attention deficit/hyperactivity disorder, IQ Intelligent quotient, +: present – : absent, n.r. data not specifically reported in the cited studies

Genetic and phenotypic characterization of the present case and comparison with other WHSUS patients with paroxysmal not-epileptic events or EEG abnormalities without seizures ADHD Attention deficit/hyperactivity disorder, IQ Intelligent quotient, +: present – : absent, n.r. data not specifically reported in the cited studies Here we report the pediatric, dysmorphological, neurological, psychometric and behavioral phenotype of a new WHSUS patient due to a novel heterozygous POGZ mutation, highlighting the distinctive epileptic phenotype, characterized by both paroxysmal not-epileptic events and EEG abnormalities without epileptic seizures, and the cognitive pattern.

Case presentation

The patient was the second child of two Caucasian non consanguineous parents. She was born by caesarean section and the perinatal history was uneventful. Her sister was affected by selective mutism. Since the first months of life, the patient presented hypotonia with consequent delay of the developmental milestones as she could sit without support at 12 months and move the first independent steps at 22 months. The child pronounced her first words at 13 months, but never achieved appropriate language skills. Bowel and bladder continence was gained at 4 years old. At the age of 3 and 6 months, the patient experienced two paroxysmal not-epileptic events characterized by lower and upper limbs stiffness, reduced response to external stimuli and eye deviation, lasting few seconds. A first sleep electroencephalogram (EEG) at this time (6 months) showed a slow background cerebral activity without epileptic abnormalities (Fig. 1A). An EEG performed at the age of 14 months showed rare spike and wave complexes over both occipital areas, with prevalence in the right hemisphere (Fig. 1B). A brain magnetic resonance (MRI) performed at the age of 3 years old showed an enlargement of the lateral ventricles and of the fronto-temporo-parietal cerebrospinal fluid spaces, associated with a cortical atrophy. At our first evaluation at 8 years old, the girl attended the first year of primary school with a special education program and practiced behavioral therapy. Dysmorphic features were present, such as high and broad forehead, bitemporal narrowing, hypertelorism, up-slanting and long palpebral fissures, midface hypoplasia, broad nasal bridge, anteverted nares, protruding tongue, macrostomy, incisors diastasis, fifth fingers clinodactyly, 4th toes brachydactyly and clinodactyly, sandal gap. She also presented esotropia and dorsal hyperkyphosis. Hearing function was unaffected. No cardiac or gastrointestinal disorders were detected. The BMI z-score was 1.84. Height and head circumference were normal. Chromosomal microarray analysis showed no abnormal results. A multi-gene analysis for neuro-developmental disorders performed using next generation sequencing showed the de novo variant p.Asp828GlyfsTer36 (c.2482dupG) in the POGZ gene (NM_015100.3), not described in the literature so far. The mutation, not reported in the population database (ExAC, EVS, 1000 genome project), causes a frameshift and a premature stop codon at the amino acid 864 over a protein length of 1410 amino acids and is considered as potentially pathogenetic according to the recommendations of the American College of Medical Genetics and Genomics (ACMG) [9]. The patient received a deep neurological and psychiatric evaluation to better define the electroencephalographic, neuropsychological and behavioral phenotypes. Clinical seizures were absent in recent medical history. Sleep EEG showed sharp waves over the bi-emispheric centro-temporal areas (Fig. 1C). At the neurological examination, muscular tone, deep tendon reflexes, cranial nerves and cerebellar function were preserved. A clumsy gait was observed. The patient presented echolalia, stereotypic hand movements, poorly modulated eye contact, repetitive behavior and restricted social interaction. Motor skills were deficient in fine movements. The following questionnaires were administered to parents to assess the presence of behavioral disturbance and psychopathological risk, and resulted in normal scores: the Aberrant Behavior Checklist (ABC) [10], exploring items related to Irritability/agitation/crying, Letargy/social withdrawal, Stereotypic behavior, Hyperactivity/non-compliance and Inappropriate speech; the Conner’s Parent Rating Scales (CPRS) [11], exploring Attention Deficit/Hyperactivity Disorder; and the Child Behavior Checklist for age 6–18 (CBCL) [12].
Fig. 1

Electroencephalograms at 6 months (A), 14 months (B) and 8 years old (C)

Electroencephalograms at 6 months (A), 14 months (B) and 8 years old (C) The Childhood Autism Rating Scale - second edition standard version (CARS-2-ST) [13] showed a total-raw score of 28.5, diagnostic for minimal symptoms of Autism Spectrum Disorders; major difficulties were found in the items “Relating people”, “Object use”, and “Taste, smell and touch response and use”. The Social Responsiveness Scales (SRS) [14] showed a pathological total T-score, with severe impairment of “Social awareness”, “Social motivation” and “Mannerisms” areas. Developmental test of Visual Motor Integration (VMI) showed deficient visual-motor integration (VMI T-score = 69, 2th percentile). Adaptive level, explored by means of the Vineland-II questionnaire [15] showed a Deviation Quotient of 81 (10th percentile), with a specific fall in “Communication Area”. This result was in line with the intellectual evaluation by Leiter-R test [16], which revealed an Intelligence Quotient (IQ) of 60, with a fluid reasoning quotient of 50, suggestive of moderate cognitive impairment. The questionnaires Sleep Disturbance Scale for Children (SDSC) and Behavioral Paediatrics Feeding Assessment Scale (BPFAS) excluded sleep and eating disorders (Table 1).

Discussion and conclusions

Mutations in the POGZ gene were identified as a novel genetic cause of developmental disorders in 2015 [17, 18]. Since then, approximately 70 individuals have been reported in the literature having various degree of intellectual disability and distinguishing facial features. However, data regarding the full phenotypic spectrum, prognosis and genotype-phenotype correlations are still incomplete. The present case further defines the mutational and clinical spectrum of POGZ-related syndrome. Besides the association of typical facial features, hypotonia, cognitive impairment and speech delay, some elements of her clinical history should be underlined. In her early life, the patient experienced two paroxysmal not-epileptic events with normal EEG and a later onset of EEG abnormalities in the absence of clinical seizures. To date, the co-existence in the same patient of paroxysmal not-epileptic events and abnormal EEG without seizures has never been reported in the literature. Paroxysmal not-epileptic events were reported in one Italian patient [7]: the child, at 4 months of age, presented paroxysmal episodes characterized by hyperextension of the upper limbs, psychomotor arrest with eye deviation and normal EEG, followed by onset of epileptic seizures requiring therapy at 2 years of age. The authors speculated that paroxysmal not-epileptic events could be an uncommon finding in WHSUS [8]. The present case shares with this patient the age of onset in the first months of life of paroxysmal not-epileptic event and the neurological symptoms characterized by lower and upper limbs stiffness, reduced response to external stimuli and eye deviation. Differently from the previous case, our patient did not develop epilepsy. However, electroencephalographic anomalies were registered from 14-months of age. Abnormal EEG without seizures have been described in two other WHSUS subjects [6] (Table 1). These observations suggest that the dissociation between convulsive episodes and EEG abnormalities could be more prevalent than expected among WHSUS patients and that this feature belongs to the wide WHSUS phenotypic spectrum. A correct diagnosis of paroxysmal not-epileptic events is crucial to avoid unnecessary pharmacological intervention and to define neurological prognosis. The comparison between the present case and other WHSUS patients with paroxysmal not-epileptic events or EEG abnormalities without seizures did not reveal a clear genotype-phenotype correlation. The mutations, inducing premature stop codons, were located in the zinc finger-domain (present case), the prolin-rich domain [7] and the DDE transposase domain [6]. The present case shares with the one described by Ferretti and colleagues [7] the occurrence of paroxysmal not-epileptic events and the presence of cortical atrophy; however, the child here described presented a milder neurological phenotype and no microcephaly. Both patients received a diagnosis of autism. The patients reported by Stessman and colleagues with EEG abnormalities without clinical epilepsy [6] presented a heterogeneous neurological involvement, one being affected by language skill regression, severe behavioral problems and microchephaly, the other by less impaired language skills and normal head circumference. No brain MRI details were provided. Both patients were not affected by autism. Compared with literature data, this case confirms the presence of a behavioral profile characterized by internalizing problems, intellectual and communication deficit [4, 5]. In addition, the behavioral evaluation highlighted the occurrence of mild autism spectrum. Of note, this condition was diagnosed by means of a neuropsychiatric clinical evaluation and specific diagnostic tests (the Childhood Autism Rating Scale and the Social Responsiveness Scales), while generic questionnaires to parents, assessing behavioral disturbance, including social withdrawal, stereotypic behaviour and communication problems, did not reveal elements of concern. This observation suggests that patients with WHSUS deserve specific evaluation for autism and that questionnaires are helpful instruments for guiding clinicians in the clinical diagnosis of autism. Autism is a known comorbidity of WHSUS but it is still poorly investigated. Specific evaluations could help detect also mild autistic phenotypes and to better define autism prevalence in POGZ-related syndrome. A complete neuropsychological evaluation should be proposed not only to precociously detect subtle autism symptoms, but also to correctly diagnose other possible behavioral disorders. Finally, patients with WHSUS present impairment of fine motor skills. Our data suggest that fine motor skills deficit may be a consequence of deficient visual-motor integration rather than of general dyspraxia. In conclusion, the dissociation between convulsive episodes and EEG anomalies suggests the importance of a periodic neurological evaluation and EEG monitoring in all patients affected by WHSUS. All patients should also receive a neuropsychological evaluation and a specific testing to precociously detect Autism Spectrum Disorders for individualized therapies tailored to patient’s needs. Special attention should be given to symptoms such as stereotypies, social withdrawal, and hyperactivity that, when present, should be considered as possible signs of autism symptoms rather than not-specific behavioral disorders.
  11 in total

1.  Expanding the phenotypic spectrum of truncating POGZ mutations: Association with CNS malformations, skeletal abnormalities, and distinctive facial dysmorphism.

Authors:  Maria Lisa Dentici; Marcello Niceta; Francesca Pantaleoni; Sabina Barresi; Paola Bencivenga; Bruno Dallapiccola; Maria Cristina Digilio; Marco Tartaglia
Journal:  Am J Med Genet A       Date:  2017-05-07       Impact factor: 2.802

2.  A case of autism spectrum disorder arising from a de novo missense mutation in POGZ.

Authors:  Ryoko Fukai; Yoko Hiraki; Hiroko Yofune; Yoshinori Tsurusaki; Mitsuko Nakashima; Hirotomo Saitsu; Fumiaki Tanaka; Noriko Miyake; Naomichi Matsumoto
Journal:  J Hum Genet       Date:  2015-02-19       Impact factor: 3.755

Review 3.  POGZ-related epilepsy: Case report and review of the literature.

Authors:  Alessandro Ferretti; Sabina Barresi; Marina Trivisano; Andrea Ciolfi; Maria L Dentici; Francesca C Radio; Federico Vigevano; Marco Tartaglia; Nicola Specchio
Journal:  Am J Med Genet A       Date:  2019-05-28       Impact factor: 2.578

Review 4.  The neurological aspects related to POGZ mutation: case report and review of CNS malformations and epilepsy.

Authors:  Debopam Samanta; Raghu Ramakrishnaiah; Bradley Schaefer
Journal:  Acta Neurol Belg       Date:  2019-03-16       Impact factor: 2.471

5.  Neuropsychological study in 19 French patients with White-Sutton syndrome and POGZ mutations.

Authors:  Aurore Garde; Jenny Cornaton; Arthur Sorlin; Sébastien Moutton; Claire Nicolas; Christine Juif; David Geneviève; Laurence Perrin; Philippe Khau-Van-Kien; Thomas Smol; Catherine Vincent-Delorme; Bertrand Isidor; Benjamin Cogné; Alexandra Afenjar; Boris Keren; Christine Coubes; Fabienne Prieur; Annick Toutain; Yann Trousselet; Solène Bourgouin; Coralie Gonin-Olympiade; Kim Giraudat; Amélie Piton; Bénédicte Gérard; Sylvie Odent; Fanny Tessier; Lola Lemasson; Solveig Heide; Anne-Claire Gelineau; Catherine Sarret; Anne Miret; Elise Schaefer; Juliette Piard; Rémi Mathevet; Marion Boucon; Ange-Line Bruel; Frederic Tran Mau-Them; Martin Chevarin; Antonio Vitobello; Christophe Philippe; Christel Thauvin-Robinet; Laurence Faivre
Journal:  Clin Genet       Date:  2020-12-15       Impact factor: 4.296

6.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Authors:  Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

7.  Disruption of POGZ Is Associated with Intellectual Disability and Autism Spectrum Disorders.

Authors:  Holly A F Stessman; Marjolein H Willemsen; Michaela Fenckova; Osnat Penn; Alexander Hoischen; Bo Xiong; Tianyun Wang; Kendra Hoekzema; Laura Vives; Ida Vogel; Han G Brunner; Ineke van der Burgt; Charlotte W Ockeloen; Janneke H Schuurs-Hoeijmakers; Jolien S Klein Wassink-Ruiter; Connie Stumpel; Servi J C Stevens; Hans S Vles; Carlo M Marcelis; Hans van Bokhoven; Vincent Cantagrel; Laurence Colleaux; Michael Nicouleau; Stanislas Lyonnet; Raphael A Bernier; Jennifer Gerdts; Bradley P Coe; Corrado Romano; Antonino Alberti; Lucia Grillo; Carmela Scuderi; Magnus Nordenskjöld; Malin Kvarnung; Hui Guo; Kun Xia; Amélie Piton; Bénédicte Gerard; David Genevieve; Bruno Delobel; Daphne Lehalle; Laurence Perrin; Fabienne Prieur; Julien Thevenon; Jozef Gecz; Marie Shaw; Rolph Pfundt; Boris Keren; Aurelia Jacquette; Annette Schenck; Evan E Eichler; Tjitske Kleefstra
Journal:  Am J Hum Genet       Date:  2016-03-03       Impact factor: 11.043

8.  Phenotypic expansion of POGZ-related intellectual disability syndrome (White-Sutton syndrome).

Authors:  Nurit Assia Batzir; Jennifer E Posey; Xiaofei Song; Zeynep Coban Akdemir; Jill A Rosenfeld; Chester W Brown; Emily Chen; Shannon G Holtrop; Elizabeth Mizerik; Margarita Nieto Moreno; Katelyn Payne; Annick Raas-Rothschild; Richard Scott; Hilary J Vernon; Neda Zadeh; James R Lupski; V Reid Sutton
Journal:  Am J Med Genet A       Date:  2019-11-29       Impact factor: 2.578

9.  Large-scale discovery of novel genetic causes of developmental disorders.

Authors: 
Journal:  Nature       Date:  2014-12-24       Impact factor: 69.504

10.  POGZ truncating alleles cause syndromic intellectual disability.

Authors:  Janson White; Christine R Beck; Tamar Harel; Jennifer E Posey; Shalini N Jhangiani; Sha Tang; Kelly D Farwell; Zöe Powis; Nancy J Mendelsohn; Janice A Baker; Lynda Pollack; Kati J Mason; Klaas J Wierenga; Daniel K Arrington; Melissa Hall; Apostolos Psychogios; Laura Fairbrother; Magdalena Walkiewicz; Richard E Person; Zhiyv Niu; Jing Zhang; Jill A Rosenfeld; Donna M Muzny; Christine Eng; Arthur L Beaudet; James R Lupski; Eric Boerwinkle; Richard A Gibbs; Yaping Yang; Fan Xia; V Reid Sutton
Journal:  Genome Med       Date:  2016-01-06       Impact factor: 15.266

View more
  2 in total

1.  A Novel POGZ Variant in a Patient with Intellectual Disability and Obesity.

Authors:  Sebastian Giraldo-Ocampo; Rafael Adrian Pacheco-Orozco; Harry Pachajoa
Journal:  Appl Clin Genet       Date:  2022-07-06

2.  Genotype-Phenotype Comparison in POGZ-Related Neurodevelopmental Disorders by Using Clinical Scoring.

Authors:  Dóra Nagy; Sarah Verheyen; Kristen M Wigby; Artem Borovikov; Artem Sharkov; Valerie Slegesky; Austin Larson; Christina Fagerberg; Charlotte Brasch-Andersen; Maria Kibæk; Ingrid Bader; Rebecca Hernan; Frances A High; Wendy K Chung; Jolanda H Schieving; Jana Behunova; Mateja Smogavec; Franco Laccone; Martina Witsch-Baumgartner; Joachim Zobel; Hans-Christoph Duba; Denisa Weis
Journal:  Genes (Basel)       Date:  2022-01-15       Impact factor: 4.141

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.